Lipitor vs. Leqvio
See how Lipitor and Leqvio compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Lipitor is a once-daily generic pill with decades of use, while Leqvio is an injection given twice a year after two starter doses.
Only Lipitor has FDA-backed evidence for directly lowering the risk of heart attack and stroke on its own.
Leqvio is typically added on top of a statin like Lipitor rather than used to replace it.
Lipitor vs. Leqvio Drug Summary
Lipitor
Lipitor (atorvastatin) is a statin that blocks a liver enzyme involved in making cholesterol, lowering LDL and triglycerides. It is taken as a once-daily oral tablet and is also used to cut the risk of heart attack and stroke in people with cardiovascular risk factors.
Leqvio
Leqvio (inclisiran) is a PCSK9 synthesis inhibitor given as a subcutaneous injection to lower LDL cholesterol as an add-on to diet and exercise. After two starter doses, it only needs to be injected twice a year to maintain its effect.
Lipitor vs. Leqvio Side Effects
Lipitor
Leqvio
Lipitor vs. Leqvio Dosage
Lipitor
Leqvio
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 10 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 284 mg single injection | Day 1 |
| Maximum dose | 284 mg single injection | Same as starting |
| Dose changes | None | Fixed dose |
Lipitor
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 10 mg once daily | Same as starting |
| Dose changes | None | Fixed dose |
Leqvio
| STAGE | DOSE | WHEN |
| Starting dose | 284 mg single injection | Day 1 |
| Maximum dose | 284 mg single injection | Same as starting |
| Dose changes | None | Fixed dose |
Lipitor vs. Leqvio Indications
Lipitor
Lipitor is approved to lower LDL cholesterol and triglycerides in adults and children 10 and older with dyslipidemia. It is also approved to reduce the risk of heart attack, stroke, and certain heart procedures in adults with cardiovascular risk factors, including type 2 diabetes.
Lowers LDL cholesterol and triglycerides in adults and kids 10+
Reduces heart attack, stroke, and heart surgery risk in high-risk adults
Reduces heart attack and stroke risk in adults with type 2 diabetes
Leqvio
Leqvio is approved as an add-on to diet and exercise to lower LDL cholesterol in adults with hypercholesterolemia. It is also approved for patients 12 and older with heterozygous or homozygous familial hypercholesterolemia.
Lowers LDL cholesterol as add-on therapy in adults with hypercholesterolemia
Lowers LDL in adults and kids 12+ with heterozygous FH
Lowers LDL in pediatric patients 12+ with homozygous FH
Lipitor vs. Leqvio Pros and Cons
Lipitor
Lipitor has nearly three decades of clinical use and strong evidence for lowering cardiovascular risk, backed by wide generic availability. Its main tradeoffs are the need for a daily pill and a risk of muscle-related side effects in some patients.
Pros
Decades of real-world data and proven reduction in heart attack and stroke risk
Widely available as a low-cost generic tablet taken at home
Approved for a broad range of patients, including children as young as 10
No boxed warning on the current label
Cons
Requires daily dosing, so missed pills can affect control
Carries a risk of muscle pain and, rarely, rhabdomyolysis
Can interact with several other medications processed by the liver
Not a good fit for patients who cannot tolerate statin-related muscle effects
Leqvio
Leqvio offers one of the least frequent dosing schedules among LDL-lowering injectables, needing only two shots a year after the starter doses. It is newer than Lipitor, with less long-term outcomes data, and requires clinic visits for administration.
Pros
Only needs two starter doses, then one injection every six months
Can help patients who cannot tolerate statin-related muscle side effects
Uses a distinct siRNA mechanism that can add LDL lowering on top of a statin
No boxed warning on the current label
Cons
Must be given by a healthcare provider, not taken at home like a pill
Newer drug with less long-term cardiovascular outcomes data than Lipitor
Carries a risk of hypersensitivity reactions including anaphylaxis and angioedema
Not approved as a standalone treatment for reducing cardiovascular events
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.